Singapore Markets close in 22 mins

BioCryst Pharmaceuticals, Inc. (BCRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.10+0.07 (+0.78%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

We're sorry, we couldn't find any data.
Please try reloading the page.

Trading information

Stock price history

Beta (5Y monthly) 2.34
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 319.99
52-week low 37.61
50-day moving average 311.90
200-day moving average 313.96

Share statistics

Avg vol (3-month) 34.83M
Avg vol (10-day) 33.58M
Shares outstanding 5179.94M
Implied shares outstanding 6N/A
Float 8166.5M
% held by insiders 10.86%
% held by institutions 175.38%
Shares short (28 Apr 2022) 430.69M
Short ratio (28 Apr 2022) 44.76
Short % of float (28 Apr 2022) 418.55%
Short % of shares outstanding (28 Apr 2022) 416.54%
Shares short (prior month 30 Mar 2022) 425.57M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021

Profitability

Profit margin -117.11%
Operating margin (ttm)-113.07%

Management effectiveness

Return on assets (ttm)-24.07%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)157.17M
Revenue per share (ttm)0.88
Quarterly revenue growth (yoy)1,074.30%
Gross profit (ttm)-58.9M
EBITDA -176.94M
Net income avi to common (ttm)-184.06M
Diluted EPS (ttm)-1.27
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)507.6M
Total cash per share (mrq)2.75
Total debt (mrq)593.24M
Total debt/equity (mrq)N/A
Current ratio (mrq)5.46
Book value per share (mrq)-0.82

Cash flow statement

Operating cash flow (ttm)-142.16M
Levered free cash flow (ttm)-122.78M